Medtronic DBS Therapy for Dystonia
Medtronic, Inc. · Decision date Nov 22, 2025
What did the FDA approve?
FDA records P960009/S482 as a supplement to PMA P960009, with the supplement type “Panel Track”. The recorded decision is approval, dated Nov 22, 2025.
FDA approval order statement
Approval for expanding the indications for use to include the following: Bilateral stimulation of the internal globus pallidus (GPi) using Medtronic DBS therapy for Dystonia is indicated as an aid in the management of chronic, intractable (oral and/or injectable medication refractory) primary dystonia, including: 1) generalized dystonia, segmental dystonia of the head and neck, and cervical dystonia (torticollis) in adult patients; and 2) generalized dystonia in pediatric patients twelve years of age or above
- Regulatory pathway
- PMA supplement
- Supplement type
- Panel Track
- Clinical specialty
- Neurology
- Decision date
- Nov 22, 2025
- FDA change category
- Labeling Change - Indications/instructions/shelf life/tradename
Regulatory record facts
- Identifier
- P960009/S482
- Regulatory pathway
- PMA supplement
- Applicant
- Medtronic, Inc.
- Product code
- SGS
- Decision code
- APPR
- Decision date
- Nov 22, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Deep Brain Stimulation for the treatment of Dystonia.
- Applicant
- Medtronic, Inc.
- Product code
- SGS
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P960009. Subsequent supplements may change the device or its indications.
FDA decision timeline
P960009 · Original PMA
MEDTRONIC ACTIVA TREMOR CONTROL SYSTEM
P960009/S482 received
Application receipt date recorded by FDA.
P960009/S510 · Related supplement
Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense
P960009/S511 · Related supplement
Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense
P960009/S513 · Related supplement
Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense
P960009/S515 · Related supplement
Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense
P960009/S516 · Related supplement
Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense
P960009/S517 · Related supplement
Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense
P960009/S519 · Related supplement
Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense
P960009/S518 · Related supplement
Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense (DBS Neurostimulator Implantable B35200); (DBS Ne
P960009/S522 · Related supplement
Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense
P960009/S523 · Related supplement
Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense
P960009/S508 · Related supplement
Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense
P960009/S521 · Related supplement
Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense
P960009/S482 · FDA decision
Panel Track
P960009/S525 · Related supplement
Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense
P960009/S524 · Related supplement
Activa Deep Brain Stimulation Therapy System, Percept PC/RC BrainSense
P960009/S514 · Related supplement
Activa Deep Brain Stimulation Therapy System
P960009/S526 · Related supplement
Activa Deep Brain Stimulation Therapy System, Percept PC; BrainSense
P960009/S527 · Related supplement
Activa Deep Brain Stimulation Therapy System; Percept PC BrainSense
P960009/S529 · Related supplement
Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense (DBS, DBS Neurostimulator Implantable, DBS Neuros
P960009/S520 · Related supplement
Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense
P960009/S528 · Related supplement
DBS Implantable Neurostimulator Models B35200, B35300; DBS Implantable Neurostimulators Activa Family Models 37601, 3760
P960009/S530 · Related supplement
Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense
P960009/S532 · Related supplement
Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense
P960009/S533 · Related supplement
Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense
P960009/S534 · Related supplement
Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense
P960009/S531 · Related supplement
Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense
P960009/S535 · Related supplement
Activa Deep Brain Stimulation Therapy System; Percept PC BrainSense (3387S, 3389S, 3550-05, B31010)
P960009/S536 · Related supplement
Activa Deep Brain Stimulation Therapy System; Percept PC BrainSense (B35200)
P960009/S537 · Related supplement
Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense
P960009/S538 · Related supplement
Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense
P960009/S540 · Related supplement
Activa Deep Brain Stimulation Therapy System; Percept PC BrainSense
P960009/S541 · Related supplement
Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense
P960009/S539 · Related supplement
Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense (B31050, B31040, B31010, B31000, B32000, B31061, B31
P960009/S543 · Related supplement
INS PERCEPT RC Vl Deep Brain Stimulation (DBS) Implantable Neurostimulators, Percept PC BrainSense TM Implantable Neur
P960009/S546 · Related supplement
MEDTRONIC ACTIVA TREMOR CONTROL SYSTEM
P960009/S542 · Related supplement
Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense
P960009/S547 · Related supplement
Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense (DBS Neurostimulator Implantable B35200)
P960009/S548 · Related supplement
Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense
P960009/S545 · Related supplement
Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense (B32000)
Timeline entries are records held by MedtechLedger for P960009. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P960009
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic, Inc. | PMA approval | Jul 31, 1997 | FDA | |
| Medtronic, Inc. | PMA supplement | Jul 17, 2025 | FDA | |
| Medtronic, Inc. | PMA supplement | Jul 17, 2025 | FDA | |
| Medtronic, Inc. | PMA supplement | Jul 22, 2025 | FDA | |
| Medtronic, Inc. | PMA supplement | Aug 6, 2025 | FDA | |
| Medtronic, Inc. | PMA supplement | Aug 28, 2025 | FDA | |
| Medtronic, Inc. | PMA supplement | Sep 5, 2025 | FDA | |
| Medtronic, Inc. | PMA supplement | Sep 15, 2025 | FDA | |
| Medtronic, Inc. | PMA supplement | Sep 18, 2025 | FDA | |
| Medtronic, Inc. | PMA supplement | Oct 16, 2025 | FDA | |
| Medtronic, Inc. | PMA supplement | Oct 23, 2025 | FDA | |
| Medtronic, Inc. | PMA supplement | Nov 4, 2025 | FDA | |
| Medtronic, Inc. | PMA supplement | Nov 13, 2025 | FDA | |
| Medtronic, Inc. | PMA supplement | Nov 26, 2025 | FDA | |
| Medtronic, Inc. | PMA supplement | Dec 8, 2025 | FDA | |
Activa Deep Brain Stimulation Therapy SystemP960009/S514 | Medtronic, Inc. | PMA supplement | Dec 17, 2025 | FDA |
| Medtronic, Inc. | PMA supplement | Dec 18, 2025 | FDA | |
| Medtronic, Inc. | PMA supplement | Dec 22, 2025 | FDA | |
| Medtronic, Inc. | PMA supplement | Feb 6, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Feb 11, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Feb 12, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Feb 27, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Apr 3, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | May 7, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | May 13, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | May 20, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | May 22, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Jun 5, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Jun 16, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Jul 6, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Aug 8, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Aug 14, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Aug 21, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Aug 21, 2026 | FDA | |
MEDTRONIC ACTIVA TREMOR CONTROL SYSTEMP960009/S546 | Medtronic, Inc. | PMA supplement | Sep 24, 2026 | FDA |
| Medtronic, Inc. | PMA supplement | Oct 6, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Oct 29, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Oct 30, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Nov 8, 2026 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic, Inc.
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 7000 Central Ave., NE, Minneapolis, MN, 55432
Sources and methodology
- Original FDA record: P960009/S482
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records